Filter news by date Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year201920182017201620152014201320122011 Apply Galderma Announces ASPIRE Rewards Program Reaches One Million Members Galderma Initiates Six New Studies, Increasing Company’s Commitment to Aesthetic Research and Innovation World-Renowned Celebrity and Fashion Manicurist Deborah Lippmann Joins Forces with Galderma on “Face Your Hands” Campaign to Help Women Achieve Younger-Looking Hands with Restylane® Lyft Nestlé Skin Health Announces the FDA Approval of Restylane® Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands Galderma Announces Results of ALAMO: A Real-World, Phase 4 Study Demonstrating Efficacy and Safety of Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Plus Oral Doxycycline 200 mg in Treating Severe Inflammatory Acne New Phase 4 OSCAR Trial Data Showed that Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Decreased Acne Lesions Therefore Reducing the Risk of Scars in Moderate-to-Severe Acne Patients Leading Acne Brand Launches First-Ever Retinoid Education Week Differin® Expands Portfolio with the Addition of Two New Facial Skincare Products Fort Worth’s Galderma, Maker of Cetaphil, Draws 524 Runners to Wonder Run 5k and 1k Kids Waddle to Benefit Children’s Skin Disease Foundation Galderma Announces FDA Approval of Restylane® Silk as the First HA Dermal Filler Approved for Injection via Cannula Galderma Names Chris Chapman to Oversee Prescription Business Unit Galderma Names Alisa Lask to Oversee Aesthetic & Corrective Business Unit Pagination Next page Next
Galderma Initiates Six New Studies, Increasing Company’s Commitment to Aesthetic Research and Innovation
World-Renowned Celebrity and Fashion Manicurist Deborah Lippmann Joins Forces with Galderma on “Face Your Hands” Campaign to Help Women Achieve Younger-Looking Hands with Restylane® Lyft
Nestlé Skin Health Announces the FDA Approval of Restylane® Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands
Galderma Announces Results of ALAMO: A Real-World, Phase 4 Study Demonstrating Efficacy and Safety of Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Plus Oral Doxycycline 200 mg in Treating Severe Inflammatory Acne
New Phase 4 OSCAR Trial Data Showed that Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Decreased Acne Lesions Therefore Reducing the Risk of Scars in Moderate-to-Severe Acne Patients
Fort Worth’s Galderma, Maker of Cetaphil, Draws 524 Runners to Wonder Run 5k and 1k Kids Waddle to Benefit Children’s Skin Disease Foundation
Galderma Announces FDA Approval of Restylane® Silk as the First HA Dermal Filler Approved for Injection via Cannula
